🇺🇸 FDA
Patent

US 7071168

Anti-cancer compounds and methods related thereto

granted A61KA61K38/00

Quick answer

US patent 7071168 (Anti-cancer compounds and methods related thereto) held by The Regents of the University of Colorado expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/00